Javascript must be enabled to continue!
Correlation between spirometric findings and 6-min walk test in patients with chronic obstructive pulmonary disease
View through CrossRef
Background: Chronic obstructive pulmonary disease (COPD) is characterized by permanent respiratory symptoms and limitation of airflow which is due to airway and/or alveolar abnormalities, caused by significant exposure to noxious particles or gases. COPD is a common, preventable, and treatable disease. The present study was undertaken to correlate the spirometric values with the result of 6MWT and to assess whether 6MWT can be used as an alternative test to spirometry in predicting the severity of COPD.
Aims and Objectives: The present study observed correlate the spirometric values with result of 6-min walk test (6MWT).
Materials and Methods: A total of 40 male and female COPD patients within the age group of 25–75 years of were part of the study. Spirometric indices forced expiratory volume 1 s(FEV1), %FEV1, forced vital capacity (FVC), FEV1/FVC ratio were recorded. Soon after the spirometry, the subjects were subjected to 6MWT. 6MWT was performed on a 30 m stretch. Distance walked in 6 min was recorded in meters. Predicted 6-min walk distance (6MWD) (For males)=561.022-(2.507×age {years})+(1.505×weight {kg})-(0.055×height {cm}) Predicted 6-min walk distance(for females)=30.325–(0.809×age {years})-(2.074×weight {kg})+(4.235×height {cm}) Patients were divided into normal (> 80%), mild impairment (60–79%), moderate impairment (40–59%), and severe impairment (<40%).
Results: Out of 40 participants, there were 15 females and 25 male participants. In age group of 25–35 years -2 males, 36–45 years-9 patients (6 females and 3 males), 46–55 years -10 cases (5 females and 5 males), 56–65 years -13 patients (3 females and 10 males), 66–75 years- 6 patients(1 female and 5 males. Correlation of 6MWD with FEV1 (P=0.00026), FEV1% predicted (P=0.000), FVC (P=0.00096), FEV1/FVC (0.001). Correlation of % predicted 6MWD with FEV1 (P=0.001), FEV1 %predicted (P=0.000), FVC (P=0.002), FEV1/FVC (0.006). There is significant positive correlation of 6MWD and % predicted 6MWD with FEV1, FEV1 predicted value, FVC, and FEV1/FVC.
Conclusion: The study results provide additional evidence that the 6MWT is a simple reproducible, inexpensive test to assess the patient’s functional capacity in the south Indian population. Further detailed studies are recommended in this area.
Pharmamedix India Publication Pvt Ltd
Title: Correlation between spirometric findings and 6-min walk test in patients with chronic obstructive pulmonary disease
Description:
Background: Chronic obstructive pulmonary disease (COPD) is characterized by permanent respiratory symptoms and limitation of airflow which is due to airway and/or alveolar abnormalities, caused by significant exposure to noxious particles or gases.
COPD is a common, preventable, and treatable disease.
The present study was undertaken to correlate the spirometric values with the result of 6MWT and to assess whether 6MWT can be used as an alternative test to spirometry in predicting the severity of COPD.
Aims and Objectives: The present study observed correlate the spirometric values with result of 6-min walk test (6MWT).
Materials and Methods: A total of 40 male and female COPD patients within the age group of 25–75 years of were part of the study.
Spirometric indices forced expiratory volume 1 s(FEV1), %FEV1, forced vital capacity (FVC), FEV1/FVC ratio were recorded.
Soon after the spirometry, the subjects were subjected to 6MWT.
6MWT was performed on a 30 m stretch.
Distance walked in 6 min was recorded in meters.
Predicted 6-min walk distance (6MWD) (For males)=561.
022-(2.
507×age {years})+(1.
505×weight {kg})-(0.
055×height {cm}) Predicted 6-min walk distance(for females)=30.
325–(0.
809×age {years})-(2.
074×weight {kg})+(4.
235×height {cm}) Patients were divided into normal (> 80%), mild impairment (60–79%), moderate impairment (40–59%), and severe impairment (<40%).
Results: Out of 40 participants, there were 15 females and 25 male participants.
In age group of 25–35 years -2 males, 36–45 years-9 patients (6 females and 3 males), 46–55 years -10 cases (5 females and 5 males), 56–65 years -13 patients (3 females and 10 males), 66–75 years- 6 patients(1 female and 5 males.
Correlation of 6MWD with FEV1 (P=0.
00026), FEV1% predicted (P=0.
000), FVC (P=0.
00096), FEV1/FVC (0.
001).
Correlation of % predicted 6MWD with FEV1 (P=0.
001), FEV1 %predicted (P=0.
000), FVC (P=0.
002), FEV1/FVC (0.
006).
There is significant positive correlation of 6MWD and % predicted 6MWD with FEV1, FEV1 predicted value, FVC, and FEV1/FVC.
Conclusion: The study results provide additional evidence that the 6MWT is a simple reproducible, inexpensive test to assess the patient’s functional capacity in the south Indian population.
Further detailed studies are recommended in this area.
Related Results
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Anxiety-depressive syndrome in patients with arterial hypertension and chronic obstructive pulmonary disease with frequent exaccations
Anxiety-depressive syndrome in patients with arterial hypertension and chronic obstructive pulmonary disease with frequent exaccations
Background. In patients with frequent exacerbations of chronic obstructive pulmonary disease occurring against the background of hypertension, there is a high level of personal neu...
DYSLIPIDEMIA AS RISK FACTOR OF ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
DYSLIPIDEMIA AS RISK FACTOR OF ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Introduction: Atherosclerosis is one of the most common co-morbidities observed in chronic obstructive pulmonary disease. A better understanding of mechanisms of
atherosclerosis in...
Dispelling Myths and Misconceptions about Chronic Obstructive Pulmonary Disease
Dispelling Myths and Misconceptions about Chronic Obstructive Pulmonary Disease
Introduction: Chronic obstructive pulmonary disease is one of the major causes of disability and mortality in the world. Despite better efforts to understand this disease, there ar...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Health Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients
Health Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients
Objective: To determine the health-related quality of life among patients suffering from chronic obstructive pulmonary disease.
Study Design: Cross sectional analytical study.
Plac...

